awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37343916-9AC1713A-4E26-4032-94E4-1E60F71740D1
Q37343916-9AC1713A-4E26-4032-94E4-1E60F71740D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37343916-9AC1713A-4E26-4032-94E4-1E60F71740D1
Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy.
P2860
Q37343916-9AC1713A-4E26-4032-94E4-1E60F71740D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37343916-9AC1713A-4E26-4032-94E4-1E60F71740D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85cb29f800f7d49e5237d87e336764f62d12775e
P2860
Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.